These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15330326)

  • 1. Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.
    Tascini C; Gemignani G; Ferranti S; Tagliaferri E; Leonildi A; Lucarini A; Menichetti F
    J Chemother; 2004 Jun; 16(3):282-7. PubMed ID: 15330326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
    Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mocchegiani F; Rocchi M; Chiodi L; Abbruzzetti A; Saba V; Scalise G; Giacometti A
    Crit Care Med; 2007 Jul; 35(7):1717-23. PubMed ID: 17452938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
    Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis.
    Tascini C; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Lambelet P; Lucarini A; Piaggesi A; Menichetti F
    J Chemother; 2006 Dec; 18(6):648-51. PubMed ID: 17267344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Sambatakou H; Galani I; Giamarellou H
    J Chemother; 2003 Jun; 15(3):235-8. PubMed ID: 12868548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Güzel CB; Gerçeker AA
    Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
    López-Fabal F; Culebras E; Bonilla I; Gómez M; Picazo JJ
    Rev Esp Quimioter; 2008 Sep; 21(3):189-93. PubMed ID: 18792821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem.
    Morelli P; Ferrario A; Tordato F; Piazza A; Casari E
    J Antimicrob Chemother; 2014 Mar; 69(3):857-9. PubMed ID: 24169582
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Guzel C; Savage PB; Gerceker AA
    Chemotherapy; 2011; 57(6):505-10. PubMed ID: 22286090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
    Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
    Di X; Wang R; Liu B; Zhang X; Ni W; Wang J; Liang B; Cai Y; Liu Y
    J Antibiot (Tokyo); 2015 Sep; 68(9):551-5. PubMed ID: 25805069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
    Araoka H; Baba M; Takagi S; Matsuno N; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Seo S; Asano-Mori Y; Uchida N; Masuoka K; Wake A; Taniguchi S; Yoneyama A
    Scand J Infect Dis; 2010 Mar; 42(3):231-3. PubMed ID: 20001223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.